Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.24.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]        
Research and development $ 1,062,672 $ 1,869,920 $ 2,332,892 $ 3,093,696
General and administrative 1,697,787 1,943,202 2,971,245 3,331,473
Total operating expenses 2,760,459 3,813,122 5,304,137 6,425,169
Loss from operations (2,760,459) (3,813,122) (5,304,137) (6,425,169)
Other (income) expenses:        
Interest expense 31,838 31,838
Interest income (75,522) (8,816) (130,720) (13,249)
Other 594 22,646 (7,063) 26,867
Other (income) expenses, net (43,090) 13,830 (105,945) 13,618
Net loss $ (2,717,369) $ (3,826,952) $ (5,198,192) $ (6,438,787)
Weighted average common shares outstanding, basic 25,789,739 25,633,217 25,711,478 24,524,856
Weighted average common shares outstanding, diluted 25,789,739 25,633,217 25,711,478 24,524,856
Net loss per share, basic $ (0.11) $ (0.15) $ (0.20) $ (0.26)
Net loss per share, diluted $ (0.11) $ (0.15) $ (0.20) $ (0.26)